Ishita Drugs And Industries Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
as on 10-12-2024
- Paid Up Capital ₹ 2.99 Cr
as on 10-12-2024
- Company Age 32 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.95 Cr
as on 10-12-2024
- Revenue -0.46%
(FY 2022)
- Profit -2.97%
(FY 2022)
- Ebitda 18.87%
(FY 2022)
- Net Worth 10.33%
(FY 2022)
- Total Assets 21.47%
(FY 2022)
About Ishita Drugs And Industries
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 524400.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 2.99 Cr.
The company currently has active open charges totaling ₹3.95 Cr.
The Key Managerial Personnel (KMP) at Ishita Drugs And Industries Limited India are Sumit Jagdishprasad as CFO and Srushti Pandya as Company Secretary. Jagdishprasad Gokulchand, Abha Jagdishprasad, Arvind Sapkal, and One other member serve as directors at the Company.
- CIN/LLPIN
L24231GJ1992PLC017054
- Company No.
017054
- Stock Symbol
BSE : 524400
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
05 Feb 1992
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Ishita Drugs And Industries Limited offer?
Ishita Drugs And Industries Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, API Intermediate.
Who are the key members and board of directors at Ishita Drugs And Industries?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jagdishprasad Gokulchand  | Managing Director | 05-Feb-1992 | Current |
| Sumit Jagdishprasad | CFO | 13-Nov-2018 | Current |
| Srushti Pandya | Company Secretary | 04-Feb-2021 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Arvind Sapkal | Director | 12-Nov-2019 | Current |
| Abha Jagdishprasad | Director | 05-Feb-1992 | Current |
| Dhwani Solanki | Director | 13-Aug-2024 | Current |
Financial Performance and Corporate Structure Insights of Ishita Drugs And Industries.
Ishita Drugs And Industries Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 0.46% decrease. The company also saw a slight decrease in profitability, with a 2.97% decrease in profit. The company's net worth Soared by an impressive increase of 10.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ishita Drugs And Industries?
In 2022, Ishita Drugs And Industries had a promoter holding of 49.31% and a public holding of 50.69%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ishita Overseas Private LimitedActive 33 years 3 monthsJagdishprasad Gokulchand and Abha Jagdishprasad are mutual person
- Umang Financial Services LimitedActive 31 years 7 months
Jagdishprasad Gokulchand is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 23 Oct 2024 | ₹2.20 Cr | Open |
Corporation Bank Creation Date: 10 May 2007 | ₹1.75 Cr | Open |
How Many Employees Work at Ishita Drugs And Industries?
Ishita Drugs And Industries has a workforce of 7 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ishita Drugs And Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ishita Drugs And Industries's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
